Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Paramedic Struck Off For Making False Job Applications
Paramedic, Ms Kim Holland has been struck off the HPC Register for

Exposure To Controversial Chemical May Be Greater Than Dose Considered Safe
People are likely being exposed to the commonly used chemical bisphenol A (BPA) at levels much higher than the recommended safe daily dose, according to a new study in monkeys. The results will be presented Thursday at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.
News of the day
Forest Biotechnology Obstructed By Anti-Biotech Groups
The potential of forest biotechnology to help address significant social and environmental issues is being "strangled at birth" by the rigid opposition of some groups and regulations that effectively preclude even the testing of genetically modified trees, scientists argue in a new report.
Health Insurance

Oncologic Drugs Advisory Committee Meeting Set By FDA

Medical Industry E-Mail News Service™ -- July 07 2009 -- The US Food & Drug Administration (FDA) has announced that its Oncologic Drugs Advisory Committee will meet on July 15 2009, in Gaithersburg MD, to discuss (1) new drug application (NDA) 022-447, proposed trade name Yondelis (trabectedin) powder, for concentrate for solution for intravenous infusion, Centocor Ortho Biotech Products, L.P., proposed indication in combination with Doxcil (doxorubicin HCl liposome injection), for treating patients with relapsed ovarian cancer; and (2) supplemental new drug application (sNDA) 050-718/S-039, Doxil (doxorubicin HCl liposome injection), for intravenous infusion, Centocor Ortho Biotech Products, L.P., proposed indication in combination with docetaxel for treating patients with locally advanced or metasatic breast cancer who have received prior anthracycline treatment. There is no charge to attend. When & Where July 15 2009; 8 am-5 pm Hilton Washington DC N/Gaithersburg Ballrooms 620 Perry Pkwy Gaithersburg MD FDA Center for Drug Evaluation & Research (HFD-21)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009